Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-12-064976
Filing Date
2012-11-27
Accepted
2012-11-27 08:41:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13GA v329299_sc13ga.htm SC 13G/A 49575
  Complete submission text file 0001144204-12-064976.txt   51115
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Subject) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79102 | Film No.: 121225495
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 156 EAST 36TH STREET 2 SNIFFEN COURT NEW YORK NY 10016
Business Address 156 EAST 36TH STREET 2 SNIFFEN COURT NEW YORK NY 10016 212 444 2500
SOPHROSYNE CAPITAL LLC (Filed by) CIK: 0001507758 (see all company filings)

EIN.: 203817380
Type: SC 13G/A